Jefferies attended Caliper Life Sciences' CALP recent 2011 Customer Owners Group event at its headquarters in Hopkinton, MA last week “where we observed an impressive pedigree of attendees, which included ~350 leading researchers from large pharmaceutical, biotech and well-heeled government/ academic labs.”
“In aggregate, attendance at the event doubled year-over-year, which we view as a compelling leading indicator of future demand trends and a powerful validation of the momentum of its new product offering amongst influential thought-leaders,” Jefferies writes.
Caliper Life Sciences closed Tuesday at $6.92.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in